Abstract
Characteristics and management of sclerosing skin diseases during immune checkpoint inhibitor therapy: An evidence-based review
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have